FDA panel sees risk in long-used osteoporosis drug
Tuesday, March 5, 2013 - 17:00
WASHINGTON (AP) -- A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer....